abstract |
The present disclosure relates to the treatment of addiction and primary impulse control disorders using phosphodiesterase 7 (PDE7) inhibitors alone or in combination with other therapeutic agents. The present invention determines that a subject has or is at risk of developing addiction, and then administers to the subject a phosphodiesterase 7 (PDE7) inhibitor effective for treating or preventing the addiction Provides a method of treating or preventing addiction. In one aspect of the invention, the subject is addictive to an addictive drug. |